Denis Vivien - Publications

Affiliations: 
INSERM U919, Cyceron, Caen, Caen, Normandie, France 
Area:
stroke, plasminogen activator, tgf-beta

124 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2020 Wagnon I, Hélie P, Bardou I, Regnauld C, Lesec L, Leprince J, Naveau M, Delaunay B, Toutirais O, Lemauff B, Etard O, Vivien D, Agin V, Macrez R, Maubert E, et al. Autoimmune encephalitis mediated by B-cell response against N-methyl-d-aspartate receptor. Brain : a Journal of Neurology. PMID 32893288 DOI: 10.1093/Brain/Awaa250  0.306
2020 Debatisse J, Wateau O, Cho TH, Costes N, Mérida I, Léon C, Langlois JB, Taborik F, Verset M, Portier K, Aggour M, Troalen T, Villien M, Makris N, Tourvieille C, ... ... Vivien D, et al. A non-human primate model of stroke reproducing endovascular thrombectomy and allowing long-term imaging and neurological read-outs. Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism. 271678X20921310. PMID 32428423 DOI: 10.1177/0271678X20921310  0.366
2020 Drieu A, Lanquetin A, Levard D, Glavan M, Campos F, Quenault A, Lemarchand E, Naveau M, Pitel AL, Castillo J, Vivien D, Rubio M. Alcohol exposure-induced neurovascular inflammatory priming impacts ischemic stroke and is linked with brain perivascular macrophages. Jci Insight. PMID 31990687 DOI: 10.1172/Jci.Insight.129226  0.323
2019 Dupré N, Arabo A, Orset C, Maucotel J, Detroussel Y, Hauchecorne M, Gonzalez BJ, Marret S, Vivien D, Leroux P. Neonatal cerebral hypoxia-ischemia in mice triggers age-dependent vascular effects and disabilities in adults; implication of tissue plasminogen activator (tPA). Experimental Neurology. 113087. PMID 31697944 DOI: 10.1016/j.expneurol.2019.113087  0.323
2019 Léger C, Dupré N, Aligny C, Bénard M, Lebon A, Henry V, Hauchecorne M, Galas L, Frebourg T, Leroux P, Vivien D, Lecointre M, Marret S, Gonzalez BJ. Glutamate controls vessel-associated migration of GABA interneurons from the pial migratory route via NMDA receptors and endothelial protease activation. Cellular and Molecular Life Sciences : Cmls. PMID 31392351 DOI: 10.1007/s00018-019-03248-5  0.34
2019 Correa-Paz C, Navarro Poupard MF, Polo E, Rodríguez-Pérez M, Taboada P, Iglesias-Rey R, Hervella P, Sobrino T, Vivien D, Castillo J, Del Pino P, Campos F, Pelaz B. In vivo ultrasound-activated delivery of recombinant tissue plasminogen activator from the cavity of sub-micrometric capsules. Journal of Controlled Release : Official Journal of the Controlled Release Society. PMID 31310784 DOI: 10.1016/J.Jconrel.2019.07.017  0.313
2019 Thiebaut AM, Hedou E, Marciniak SJ, Vivien D, Roussel BD. Proteostasis During Cerebral Ischemia. Frontiers in Neuroscience. 13: 637. PMID 31275110 DOI: 10.3389/fnins.2019.00637  0.363
2019 Lenoir S, Varangot A, Lebouvier L, Galli T, Hommet Y, Vivien D. Post-synaptic Release of the Neuronal Tissue-Type Plasminogen Activator (tPA). Frontiers in Cellular Neuroscience. 13: 164. PMID 31105531 DOI: 10.3389/fncel.2019.00164  0.311
2018 Gauberti M, Lapergue B, Martinez de Lizarrondo S, Vivien D, Richard S, Bracard S, Piotin M, Gory B. Ischemia-Reperfusion Injury After Endovascular Thrombectomy for Ischemic Stroke. Stroke. 49: 3071-3074. PMID 30571423 DOI: 10.1161/STROKEAHA.118.022015  0.306
2018 Thiebaut AM, Gauberti M, Ali C, Martinez De Lizarrondo S, Vivien D, Yepes M, Roussel BD. The role of plasminogen activators in stroke treatment: fibrinolysis and beyond. The Lancet. Neurology. 17: 1121-1132. PMID 30507392 DOI: 10.1016/S1474-4422(18)30323-5  0.362
2018 Pasquet N, Douceau S, Naveau M, Lesept F, Louessard M, Lebouvier L, Hommet Y, Vivien D, Bardou I. Tissue-Type Plasminogen Activator Controlled Corticogenesis Through a Mechanism Dependent of NMDA Receptors Expressed on Radial Glial Cells. Cerebral Cortex (New York, N.Y. : 1991). PMID 29878094 DOI: 10.1093/cercor/bhy119  0.353
2018 Roth S, Singh V, Tiedt S, Schindler L, Huber G, Geerlof A, Antoine DJ, Anfray A, Orset C, Gauberti M, Fournier A, Holdt LM, Harris HE, Engelhardt B, Bianchi ME, ... Vivien D, et al. Brain-released alarmins and stress response synergize in accelerating atherosclerosis progression after stroke. Science Translational Medicine. 10. PMID 29540615 DOI: 10.1126/Scitranslmed.Aao1313  0.583
2017 Iglesias-Rey R, Rodríguez-Yáñez M, Rodríguez-Castro E, Pumar JM, Arias S, Santamaría M, López-Dequidt I, Hervella P, Correa-Paz C, Sobrino T, Vivien D, Campos F, Castellanos M, Castillo J. Worse Outcome in Stroke Patients Treated with rt-PA Without Early Reperfusion: Associated Factors. Translational Stroke Research. PMID 29116527 DOI: 10.1007/S12975-017-0584-9  0.321
2017 Vaur P, Brugg B, Mericskay M, Li Z, Schmidt MS, Vivien D, Orset C, Jacotot E, Brenner C, Duplus E. Nicotinamide riboside, a form of vitamin B3, protects against excitotoxicity-induced axonal degeneration. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. PMID 28842432 DOI: 10.1096/Fj.201700221Rr  0.338
2017 Lecuyer M, Rubio M, Chollat C, Lecointre M, Jégou S, Leroux P, Cleren C, Leroux-Nicollet I, Marpeau L, Vivien D, Marret S, Gonzalez BJ. Experimental and clinical evidence of differential effects of magnesium sulfate on neuroprotection and angiogenesis in the fetal brain. Pharmacology Research & Perspectives. 5. PMID 28805973 DOI: 10.1002/prp2.315  0.308
2017 Llovera G, Benakis C, Enzmann G, Cai R, Arzberger T, Ghasemigharagoz A, Mao X, Malik R, Lazarevic I, Liebscher S, Ertürk A, Meissner L, Vivien D, Haffner C, Plesnila N, et al. The choroid plexus is a key cerebral invasion route for T cells after stroke. Acta Neuropathologica. PMID 28762187 DOI: 10.1007/S00401-017-1758-Y  0.569
2017 Louessard M, Bardou I, Lemarchand E, Thiebaut AM, Parcq J, Leprince J, Terrisse A, Carraro V, Fafournoux P, Bruhat A, Orset C, Vivien D, Ali C, Roussel BD. Activation of cell surface GRP78 decreases endoplasmic reticulum stress and neuronal death. Cell Death and Differentiation. PMID 28644439 DOI: 10.1038/cdd.2017.35  0.35
2017 Martinez de Lizarrondo S, Gakuba C, Herbig BA, Repessé Y, Ali C, Denis CV, Lenting P, Touzé E, Diamond SL, Vivien D, Gauberti M. Potent Thrombolytic Effect of N-Acetylcysteine on Arterial Thrombi. Circulation. PMID 28487393 DOI: 10.1161/Circulationaha.117.027290  0.333
2017 Briens A, Bardou I, Lebas H, Miles LA, Parmer RJ, Vivien D, Docagne F. Astrocytes regulate the balance between plasminogen activation and plasmin clearance via cell-surface actin. Cell Discovery. 3: 17001. PMID 28417010 DOI: 10.1038/Celldisc.2017.1  0.339
2017 Roncal C, Martinez de Lizarrondo S, Salicio A, Chevilley A, Rodriguez JA, Rosell A, Couraud PO, Weksler B, Montaner J, Vivien D, Páramo JA, Orbe J. New thrombolytic strategy providing neuroprotection in experimental ischemic stroke: MMP10 alone or in combination with tPA. Cardiovascular Research. PMID 28379489 DOI: 10.1093/cvr/cvx069  0.326
2017 Quattromani MJ, Pruvost M, Guerreiro C, Backlund F, Englund E, Aspberg A, Jaworski T, Hakon J, Ruscher K, Kaczmarek L, Vivien D, Wieloch T. Extracellular Matrix Modulation Is Driven by Experience-Dependent Plasticity During Stroke Recovery. Molecular Neurobiology. PMID 28290150 DOI: 10.1007/S12035-017-0461-2  0.38
2017 Lemarchant S, Wojciechowski S, Vivien D, Koistinaho J. ADAMTS-4 in central nervous system pathologies. Journal of Neuroscience Research. PMID 28084617 DOI: 10.1002/Jnr.24021  0.314
2017 Dhungana H, Huuskonen MT, Pihlajaniemi T, Heljasvaara R, Vivien D, Kanninen KM, Malm T, Koistinaho J, Lemarchant S. Lack of collagen XV is protective after ischemic stroke in mice. Cell Death & Disease. 8: e2541. PMID 28079884 DOI: 10.1038/Cddis.2016.456  0.35
2017 Demuth HU, Dijkhuizen RM, Farr TD, Gelderblom M, Horsburgh K, Iadecola C, Mcleod DD, Michalski D, Murphy TH, Orbe J, Otte WM, Petzold GC, Plesnila N, Reiser G, Reymann KG, ... ... Vivien D, et al. Recent progress in translational research on neurovascular and neurodegenerative disorders. Restorative Neurology and Neuroscience. PMID 28059802 DOI: 10.3233/Rnn-160690  0.31
2016 Lesept F, Chevilley A, Jezequel J, Ladépêche L, Macrez R, Aimable M, Lenoir S, Bertrand T, Rubrecht L, Galea P, Lebouvier L, Petersen KU, Hommet Y, Maubert E, Ali C, ... ... Vivien D, et al. Tissue-type plasminogen activator controls neuronal death by raising surface dynamics of extrasynaptic NMDA receptors. Cell Death & Disease. 7: e2466. PMID 27831563 DOI: 10.1038/cddis.2016.279  0.363
2016 Leys D, Hommet Y, Jacquet C, Moulin S, Sibon I, Mas JL, Moulin T, Giroud M, Sagnier S, Cordonnier C, Medeiros de Bustos E, Turc G, Ronzière T, Bejot Y, Detante O, ... ... Vivien D, et al. Proportion of single-chain recombinant tissue plasminogen activator and outcome after stroke. Neurology. PMID 27815401 DOI: 10.1212/WNL.0000000000003399  0.311
2016 Hébert M, Anfray A, Chevilley A, Martinez de Lizarrondo S, Quenault A, Louessard M, Roussel BD, Obiang P, Save E, Orset C, Maubert E, Vivien D, Agin V. Distant Space Processing is Controlled by tPA-dependent NMDA Receptor Signaling in the Entorhinal Cortex. Cerebral Cortex (New York, N.Y. : 1991). PMID 27613436 DOI: 10.1093/cercor/bhw275  0.355
2016 Macrez R, Stys PK, Vivien D, Lipton SA, Docagne F. Mechanisms of glutamate toxicity in multiple sclerosis: biomarker and therapeutic opportunities. The Lancet. Neurology. 15: 1089-1102. PMID 27571160 DOI: 10.1016/S1474-4422(16)30165-X  0.338
2016 Marcos-Contreras OA, Martinez de Lizarrondo S, Bardou I, Orset C, Pruvost M, Anfray A, Frigout Y, Hommet Y, Lebouvier L, Montaner J, Vivien D, Gauberti M. Hyperfibrinolysis increases blood brain barrier permeability by a plasmin and bradykinin-dependent mechanism. Blood. PMID 27531677 DOI: 10.1182/blood-2016-03-705384  0.383
2016 Macrez R, Ortega MC, Bardou I, Mehra A, Fournier A, Van der Pol SM, Haelewyn B, Maubert E, Lesept F, Chevilley A, de Castro F, De Vries HE, Vivien D, Clemente D, Docagne F. Neuroendothelial NMDA receptors as therapeutic targets in experimental autoimmune encephalomyelitis. Brain : a Journal of Neurology. PMID 27435092 DOI: 10.1093/brain/aww172  0.325
2016 Orset C, Haelewyn B, Allan SM, Ansar S, Campos F, Cho TH, Durand A, El Amki M, Fatar M, Garcia-Yébenes I, Gauberti M, Grudzenski S, Lizasoain I, Lo E, Macrez R, ... ... Vivien D, et al. Efficacy of Alteplase in a Mouse Model of Acute Ischemic Stroke: A Retrospective Pooled Analysis. Stroke; a Journal of Cerebral Circulation. PMID 27032444 DOI: 10.1161/Strokeaha.116.012238  0.341
2015 Maysami S, Wong R, Pradillo JM, Denes A, Dhungana H, Malm T, Koistinaho J, Orset C, Rahman M, Rubio M, Schwaninger M, Vivien D, Bath PM, Rothwell NJ, Allan SM. A cross-laboratory preclinical study on the effectiveness of interleukin-1 receptor antagonist in stroke. Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism. PMID 26661169 DOI: 10.1177/0271678X15606714  0.36
2015 Hébert M, Lesept F, Vivien D, Macrez R. The story of an exceptional serine protease, tissue-type plasminogen activator (tPA). Revue Neurologique. PMID 26626577 DOI: 10.1016/j.neurol.2015.10.002  0.407
2015 Chevilley A, Lesept F, Lenoir S, Ali C, Parcq J, Vivien D. Impacts of tissue-type plasminogen activator (tPA) on neuronal survival. Frontiers in Cellular Neuroscience. 9: 415. PMID 26528141 DOI: 10.3389/fncel.2015.00415  0.387
2015 Bertrand T, Lesept F, Chevilley A, Lenoir S, Aimable M, Briens A, Hommet Y, Bardou I, Parcq J, Vivien D. Conformations of tissue plasminogen activator (tPA) orchestrate neuronal survival by a crosstalk between EGFR and NMDAR. Cell Death & Disease. 6: e1924. PMID 26469972 DOI: 10.1038/cddis.2015.296  0.384
2015 Louessard M, Lacroix A, Martineau M, Mondielli G, Montagne A, Lesept F, Lambolez B, Cauli B, Mothet JP, Vivien D, Maubert E. Tissue Plasminogen Activator Expression Is Restricted to Subsets of Excitatory Pyramidal Glutamatergic Neurons. Molecular Neurobiology. PMID 26377106 DOI: 10.1007/S12035-015-9432-7  0.375
2015 Llovera G, Hofmann K, Roth S, Salas-Pérdomo A, Ferrer-Ferrer M, Perego C, Zanier ER, Mamrak U, Rex A, Party H, Agin V, Fauchon C, Orset C, Haelewyn B, De Simoni MG, ... ... Vivien D, et al. Results of a preclinical randomized controlled multicenter trial (pRCT): Anti-CD49d treatment for acute brain ischemia. Science Translational Medicine. 7: 299ra121. PMID 26246166 DOI: 10.1126/Scitranslmed.Aaa9853  0.341
2015 Lemarchand E, Maubert E, Haelewyn B, Ali C, Rubio M, Vivien D. Stressed neurons protect themselves by a tissue-type plasminogen activator-mediated EGFR-dependent mechanism. Cell Death and Differentiation. PMID 26068590 DOI: 10.1038/cdd.2015.76  0.435
2015 Lemarchand E, Gauberti M, Martinez de Lizarrondo S, Villain H, Repessé Y, Montagne A, Vivien D, Ali C, Rubio M. Impact of alcohol consumption on the outcome of ischemic stroke and thrombolysis: role of the hepatic clearance of tissue-type plasminogen activator. Stroke; a Journal of Cerebral Circulation. 46: 1641-50. PMID 25922513 DOI: 10.1161/STROKEAHA.114.007143  0.337
2015 Joshi AU, Orset C, Engelhardt B, Baumgart-Vogt E, Gerriets T, Vivien D, Kanse SM. Deficiency of Factor VII activating protease alters the outcome of ischemic stroke in mice. The European Journal of Neuroscience. 41: 965-75. PMID 25615590 DOI: 10.1111/Ejn.12830  0.755
2015 Merino-Zamorano C, Hernández-Guillamon M, Jullienne A, Le Béhot A, Bardou I, Parés M, Fernández-Cadenas I, Giralt D, Carrera C, Ribó M, Vivien D, Ali C, Rosell A, Montaner J. NURR1 involvement in recombinant tissue-type plasminogen activator treatment complications after ischemic stroke. Stroke; a Journal of Cerebral Circulation. 46: 477-84. PMID 25503547 DOI: 10.1161/STROKEAHA.114.006826  0.36
2015 Balossier A, Orset C, Etard O, Gakuba C, Emery E, Vivien D. Effects of epidural cortical stimulation on motor recovery after a primary motor cortex ischemic stroke: preliminary results in a non-human primate model Brain Stimulation. 8: 430. DOI: 10.1016/J.Brs.2015.01.371  0.305
2014 Gaberel T, Gakuba C, Goulay R, Martinez De Lizarrondo S, Hanouz JL, Emery E, Touze E, Vivien D, Gauberti M. Impaired glymphatic perfusion after strokes revealed by contrast-enhanced MRI: a new target for fibrinolysis? Stroke; a Journal of Cerebral Circulation. 45: 3092-6. PMID 25190438 DOI: 10.1161/STROKEAHA.114.006617  0.321
2014 Gaberel T, Montagne A, Lesept F, Gauberti M, Lemarchand E, Orset C, Goulay R, Bertrand T, Emery E, Vivien D. Urokinase versus Alteplase for intraventricular hemorrhage fibrinolysis. Neuropharmacology. 85: 158-65. PMID 24846802 DOI: 10.1016/j.neuropharm.2014.05.001  0.357
2013 Lemarchant S, Pruvost M, Montaner J, Emery E, Vivien D, Kanninen K, Koistinaho J. ADAMTS proteoglycanases in the physiological and pathological central nervous system. Journal of Neuroinflammation. 10: 133. PMID 24176075 DOI: 10.1186/1742-2094-10-133  0.308
2013 Parcq J, Bertrand T, Baron AF, Hommet Y, Anglès-Cano E, Vivien D. Molecular requirements for safer generation of thrombolytics by bioengineering the tissue-type plasminogen activator A chain. Journal of Thrombosis and Haemostasis : Jth. 11: 539-46. PMID 23301636 DOI: 10.1111/jth.12128  0.314
2013 Gaberel T, Macrez R, Gauberti M, Montagne A, Hebert M, Petersen KU, Touze E, Agin V, Emery E, Ali C, Vivien D. Immunotherapy blocking the tissue plasminogen activator-dependent activation of N-methyl-D-aspartate glutamate receptors improves hemorrhagic stroke outcome. Neuropharmacology. 67: 267-71. PMID 23219658 DOI: 10.1016/j.neuropharm.2012.11.023  0.433
2013 Henry VJ, Lecointre M, Laudenbach V, Ali C, Macrez R, Jullienne A, Berezowski V, Carmeliet P, Vivien D, Marret S, Gonzalez BJ, Leroux P. High t-PA release by neonate brain microvascular endothelial cells under glutamate exposure affects neuronal fate. Neurobiology of Disease. 50: 201-8. PMID 23103420 DOI: 10.1016/j.nbd.2012.10.020  0.388
2012 Kaindl AM, Degos V, Peineau S, Gouadon E, Chhor V, Loron G, Le Charpentier T, Josserand J, Ali C, Vivien D, Collingridge GL, Lombet A, Issa L, Rene F, Loeffler JP, et al. Activation of microglial N-methyl-D-aspartate receptors triggers inflammation and neuronal cell death in the developing and mature brain. Annals of Neurology. 72: 536-49. PMID 23109148 DOI: 10.1002/ana.23626  0.416
2012 Obiang P, Macrez R, Jullienne A, Bertrand T, Lesept F, Ali C, Maubert E, Vivien D, Agin V. GluN2D subunit-containing NMDA receptors control tissue plasminogen activator-mediated spatial memory. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 32: 12726-34. PMID 22972996 DOI: 10.1523/JNEUROSCI.6202-11.2012  0.369
2012 Montagne A, Hébert M, Jullienne A, Lesept F, Le Béhot A, Louessard M, Gauberti M, Orset C, Ali C, Agin V, Maubert E, Vivien D. Memantine improves safety of thrombolysis for stroke. Stroke; a Journal of Cerebral Circulation. 43: 2774-81. PMID 22879098 DOI: 10.1161/STROKEAHA.112.669374  0.395
2012 Montagne A, Gauberti M, Macrez R, Jullienne A, Briens A, Raynaud JS, Louin G, Buisson A, Haelewyn B, Docagne F, Defer G, Vivien D, Maubert E. Ultra-sensitive molecular MRI of cerebrovascular cell activation enables early detection of chronic central nervous system disorders. Neuroimage. 63: 760-70. PMID 22813950 DOI: 10.1016/j.neuroimage.2012.07.018  0.663
2012 Cassé F, Bardou I, Danglot L, Briens A, Montagne A, Parcq J, Alahari A, Galli T, Vivien D, Docagne F. Glutamate controls tPA recycling by astrocytes, which in turn influences glutamatergic signals. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 32: 5186-99. PMID 22496564 DOI: 10.1523/Jneurosci.5296-11.2012  0.393
2012 Gauberti M, Obiang P, Guedin P, Balossier A, Gakuba C, Diependaele AS, Chazalviel L, Vivien D, Young AR, Agin V, Orset C. Thrombotic stroke in the anesthetized monkey (Macaca mulatta): characterization by MRI--a pilot study. Cerebrovascular Diseases (Basel, Switzerland). 33: 329-39. PMID 22343114 DOI: 10.1159/000335309  0.337
2012 Danglot L, Zylbersztejn K, Petkovic M, Gauberti M, Meziane H, Combe R, Champy MF, Birling MC, Pavlovic G, Bizot JC, Trovero F, Della Ragione F, Proux-Gillardeaux V, Sorg T, Vivien D, et al. Absence of TI-VAMP/Vamp7 leads to increased anxiety in mice. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 32: 1962-8. PMID 22323709 DOI: 10.1523/Jneurosci.4436-11.2012  0.332
2011 Orbe J, Barrenetxe J, Rodriguez JA, Vivien D, Orset C, Parks WC, Birkland TP, Serrano R, Purroy A, Martinez de Lizarrondo S, Angles-Cano E, Páramo JA. Matrix metalloproteinase-10 effectively reduces infarct size in experimental stroke by enhancing fibrinolysis via a thrombin-activatable fibrinolysis inhibitor-mediated mechanism. Circulation. 124: 2909-19. PMID 22104553 DOI: 10.1161/CIRCULATIONAHA.111.047100  0.322
2011 Jullienne A, Montagne A, Orset C, Lesept F, Jane DE, Monaghan DT, Maubert E, Vivien D, Ali C. Selective inhibition of GluN2D-containing N-methyl-D-aspartate receptors prevents tissue plasminogen activator-promoted neurotoxicity both in vitro and in vivo. Molecular Neurodegeneration. 6: 68. PMID 21975018 DOI: 10.1186/1750-1326-6-68  0.415
2011 Raoult E, Roussel BD, Bénard M, Lefebvre T, Ravni A, Ali C, Vivien D, Komuro H, Fournier A, Vaudry H, Vaudry D, Galas L. Pituitary adenylate cyclase-activating polypeptide (PACAP) stimulates the expression and the release of tissue plasminogen activator (tPA) in neuronal cells: involvement of tPA in the neuroprotective effect of PACAP. Journal of Neurochemistry. 119: 920-31. PMID 21919910 DOI: 10.1111/J.1471-4159.2011.07486.X  0.358
2011 Rubio M, Villain H, Docagne F, Roussel BD, Ramos JA, Vivien D, Fernandez-Ruiz J, Ali C. Pharmacological activation/inhibition of the cannabinoid system affects alcohol withdrawal-induced neuronal hypersensitivity to excitotoxic insults. Plos One. 6: e23690. PMID 21886913 DOI: 10.1371/journal.pone.0023690  0.344
2011 Meissirel C, Ruiz de Almodovar C, Knevels E, Coulon C, Chounlamountri N, Segura I, de Rossi P, Vinckier S, Anthonis K, Deléglise B, de Mol M, Ali C, Dassonville K, Loyens E, Honnorat J, ... ... Vivien D, et al. VEGF modulates NMDA receptors activity in cerebellar granule cells through Src-family kinases before synapse formation. Proceedings of the National Academy of Sciences of the United States of America. 108: 13782-7. PMID 21804034 DOI: 10.1073/Pnas.1100341108  0.319
2011 Macrez R, Obiang P, Gauberti M, Roussel B, Baron A, Parcq J, Cassé F, Hommet Y, Orset C, Agin V, Bezin L, Berrocoso TG, Petersen KU, Montaner J, Maubert E, ... Vivien D, et al. Antibodies preventing the interaction of tissue-type plasminogen activator with N-methyl-D-aspartate receptors reduce stroke damages and extend the therapeutic window of thrombolysis. Stroke; a Journal of Cerebral Circulation. 42: 2315-22. PMID 21680906 DOI: 10.1161/STROKEAHA.110.606293  0.408
2011 Roussel BD, Mysiorek C, Rouhiainen A, Jullienne A, Parcq J, Hommet Y, Culot M, Berezowski V, Cecchelli R, Rauvala H, Vivien D, Ali C. HMGB-1 promotes fibrinolysis and reduces neurotoxicity mediated by tissue plasminogen activator. Journal of Cell Science. 124: 2070-6. PMID 21610098 DOI: 10.1242/jcs.084392  0.43
2011 Correa F, Gauberti M, Parcq J, Macrez R, Hommet Y, Obiang P, Hernangómez M, Montagne A, Liot G, Guaza C, Maubert E, Ali C, Vivien D, Docagne F. Tissue plasminogen activator prevents white matter damage following stroke. The Journal of Experimental Medicine. 208: 1229-42. PMID 21576385 DOI: 10.1084/jem.20101880  0.405
2009 Roussel BD, Hommet Y, Macrez R, Schulz T, Petersen KU, Berezowski V, Cecchelli R, Ali C, Vivien D. PPACK-Desmodus rotundus salivary plasminogen activator (cDSPAalpha1) prevents the passage of tissue-type plasminogen activator (rt-PA) across the blood-brain barrier and neurotoxicity. Thrombosis and Haemostasis. 102: 606-8. PMID 19718485 DOI: 10.1160/TH09-02-0114  0.342
2009 Culot M, Mysiorek C, Renftel M, Roussel BD, Hommet Y, Vivien D, Cecchelli R, Fenart L, Berezowski V, Dehouck MP, Lundquist S. Cerebrovascular protection as a possible mechanism for the protective effects of NXY-059 in preclinical models: an in vitro study. Brain Research. 1294: 144-52. PMID 19631615 DOI: 10.1016/j.brainres.2009.07.035  0.361
2009 Roussel BD, Macrez R, Jullienne A, Agin V, Maubert E, Dauphinot L, Potier MC, Plawinski L, Castel H, Hommet Y, Munuera J, Montaner J, Yepes M, Ali C, Vivien D. Age and albumin D site-binding protein control tissue plasminogen activator levels: neurotoxic impact. Brain : a Journal of Neurology. 132: 2219-30. PMID 19574439 DOI: 10.1093/brain/awp162  0.384
2009 Legros H, Launay S, Roussel BD, Marcou-Labarre A, Calbo S, Catteau J, Leroux P, Boyer O, Ali C, Marret S, Vivien D, Laudenbach V. Newborn- and adult-derived brain microvascular endothelial cells show age-related differences in phenotype and glutamate-evoked protease release. Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism. 29: 1146-58. PMID 19367295 DOI: 10.1038/Jcbfm.2009.39  0.338
2009 Yepes M, Roussel BD, Ali C, Vivien D. Tissue-type plasminogen activator in the ischemic brain: more than a thrombolytic. Trends in Neurosciences. 32: 48-55. PMID 18963068 DOI: 10.1016/j.tins.2008.09.006  0.39
2008 Lebeurrier N, Launay S, Macrez R, Maubert E, Legros H, Leclerc A, Jamin SP, Picard JY, Marret S, Laudenbach V, Berger P, Sonderegger P, Ali C, di Clemente N, Vivien D. Anti-Mullerian-hormone-dependent regulation of the brain serine-protease inhibitor neuroserpin. Journal of Cell Science. 121: 3357-65. PMID 18796535 DOI: 10.1242/Jcs.031872  0.422
2008 Launay S, Maubert E, Lebeurrier N, Tennstaedt A, Campioni M, Docagne F, Gabriel C, Dauphinot L, Potier MC, Ehrmann M, Baldi A, Vivien D. HtrA1-dependent proteolysis of TGF-beta controls both neuronal maturation and developmental survival. Cell Death and Differentiation. 15: 1408-16. PMID 18551132 DOI: 10.1038/cdd.2008.82  0.392
2008 Lopez-Atalaya JP, Roussel BD, Levrat D, Parcq J, Nicole O, Hommet Y, Benchenane K, Castel H, Leprince J, To Van D, Bureau R, Rault S, Vaudry H, Petersen KU, Santos JS, ... ... Vivien D, et al. Toward safer thrombolytic agents in stroke: molecular requirements for NMDA receptor-mediated neurotoxicity. Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism. 28: 1212-21. PMID 18334994 DOI: 10.1038/jcbfm.2008.14  0.717
2008 Endres M, Engelhardt B, Koistinaho J, Lindvall O, Meairs S, Mohr JP, Planas A, Rothwell N, Schwaninger M, Schwab ME, Vivien D, Wieloch T, Dirnagl U. Improving outcome after stroke: overcoming the translational roadblock. Cerebrovascular Diseases (Basel, Switzerland). 25: 268-78. PMID 18292653 DOI: 10.1159/000118039  0.569
2008 Endres M, Engelhardt B, Koistinaho J, Lindvall O, Meairs S, Mohr JP, Planas A, Rothwell N, Schwaninger M, Schwab ME, Vivien D, Wieloch T, Dirnagl U, Keezer MR, Yu AYX, et al. EUSI-ESO News Cerebrovascular Diseases. 25: 288-288. DOI: 10.1159/000122836  0.464
2007 Young AR, Ali C, Duretête A, Vivien D. Neuroprotection and stroke: time for a compromise. Journal of Neurochemistry. 103: 1302-9. PMID 17727635 DOI: 10.1111/j.1471-4159.2007.04866.x  0.318
2007 Orset C, Macrez R, Young AR, Panthou D, Angles-Cano E, Maubert E, Agin V, Vivien D. Mouse model of in situ thromboembolic stroke and reperfusion. Stroke; a Journal of Cerebral Circulation. 38: 2771-8. PMID 17702959 DOI: 10.1161/STROKEAHA.107.487520  0.407
2007 Cacquevel M, Launay S, Castel H, Benchenane K, Chéenne S, Buée L, Moons L, Delacourte A, Carmeliet P, Vivien D. Ageing and amyloid-beta peptide deposition contribute to an impaired brain tissue plasminogen activator activity by different mechanisms. Neurobiology of Disease. 27: 164-73. PMID 17566751 DOI: 10.1016/J.Nbd.2007.04.004  0.702
2007 López-Atalaya JP, Roussel BD, Ali C, Maubert E, Petersen KU, Berezowski V, Cecchelli R, Orset C, Vivien D. Recombinant Desmodus rotundus salivary plasminogen activator crosses the blood-brain barrier through a low-density lipoprotein receptor-related protein-dependent mechanism without exerting neurotoxic effects. Stroke; a Journal of Cerebral Circulation. 38: 1036-43. PMID 17325305 DOI: 10.1161/01.STR.0000258100.04923.84  0.414
2007 Benchenane K, Castel H, Boulouard M, Bluthé R, Fernandez-Monreal M, Roussel BD, Lopez-Atalaya JP, Butt-Gueulle S, Agin V, Maubert E, Dantzer R, Touzani O, Dauphin F, Vivien D, Ali C. Anti-NR1 N-terminal-domain vaccination unmasks the crucial action of tPA on NMDA-receptor-mediated toxicity and spatial memory. Journal of Cell Science. 120: 578-85. PMID 17244650 DOI: 10.1242/Jcs.03354  0.798
2006 Liot G, Roussel BD, Lebeurrier N, Benchenane K, López-Atalaya JP, Vivien D, Ali C. Tissue-type plasminogen activator rescues neurones from serum deprivation-induced apoptosis through a mechanism independent of its proteolytic activity. Journal of Neurochemistry. 98: 1458-64. PMID 16800849 DOI: 10.1111/j.1471-4159.2006.03982.x  0.728
2006 Meairs S, Wahlgren N, Dirnagl U, Lindvall O, Rothwell P, Baron JC, Hossmann K, Engelhardt B, Ferro J, McCulloch J, Kaste M, Endres M, Koistinaho J, Planas A, Vivien D, et al. Stroke research priorities for the next decade--A representative view of the European scientific community. Cerebrovascular Diseases (Basel, Switzerland). 22: 75-82. PMID 16790993 DOI: 10.1159/000093098  0.544
2006 López-Atalaya J, Roussel B, Levrat D, Nicole O, Benchenane K, Rault S, Vaudry H, Petersen K, Ali C, Vivien D. ID: 96 Molecular requirements for modulation of NMDA receptor signaling by tissue-type plasminogen activator Journal of Thrombosis and Haemostasis. 4: 185-185. DOI: 10.1111/J.1538-7836.2006.00096.X  0.708
2005 Lesné S, Ali C, Gabriel C, Croci N, MacKenzie ET, Glabe CG, Plotkine M, Marchand-Verrecchia C, Vivien D, Buisson A. NMDA receptor activation inhibits alpha-secretase and promotes neuronal amyloid-beta production. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 25: 9367-77. PMID 16221845 DOI: 10.1523/Jneurosci.0849-05.2005  0.719
2005 Lebeurrier N, Liot G, Lopez-Atalaya JP, Orset C, Fernandez-Monreal M, Sonderegger P, Ali C, Vivien D. The brain-specific tissue-type plasminogen activator inhibitor, neuroserpin, protects neurons against excitotoxicity both in vitro and in vivo. Molecular and Cellular Neurosciences. 30: 552-8. PMID 16209928 DOI: 10.1016/J.Mcn.2005.09.005  0.462
2005 Lin AH, Luo J, Mondshein LH, ten Dijke P, Vivien D, Contag CH, Wyss-Coray T. Global analysis of Smad2/3-dependent TGF-beta signaling in living mice reveals prominent tissue-specific responses to injury. Journal of Immunology (Baltimore, Md. : 1950). 175: 547-54. PMID 15972691 DOI: 10.4049/Jimmunol.175.1.547  0.366
2005 Benchenane K, Berezowski V, Ali C, Fernández-Monreal M, López-Atalaya JP, Brillault J, Chuquet J, Nouvelot A, MacKenzie ET, Bu G, Cecchelli R, Touzani O, Vivien D. Tissue-type plasminogen activator crosses the intact blood-brain barrier by low-density lipoprotein receptor-related protein-mediated transcytosis. Circulation. 111: 2241-9. PMID 15851587 DOI: 10.1161/01.CIR.0000163542.48611.A2  0.796
2005 Gaertner RF, Wyss-Coray T, Von Euw D, Lesné S, Vivien D, Lacombe P. Reduced brain tissue perfusion in TGF-beta 1 transgenic mice showing Alzheimer's disease-like cerebrovascular abnormalities. Neurobiology of Disease. 19: 38-46. PMID 15837559 DOI: 10.1016/J.Nbd.2004.11.008  0.34
2005 Benchenane K, Berezowski V, Fernández-Monreal M, Brillault J, Valable S, Dehouck MP, Cecchelli R, Vivien D, Touzani O, Ali C. Oxygen glucose deprivation switches the transport of tPA across the blood-brain barrier from an LRP-dependent to an increased LRP-independent process. Stroke; a Journal of Cerebral Circulation. 36: 1065-70. PMID 15817895 DOI: 10.1161/01.STR.0000163050.39122.4f  0.794
2005 Lesné S, Gabriel C, Nelson DA, White E, Mackenzie ET, Vivien D, Buisson A. Akt-dependent expression of NAIP-1 protects neurons against amyloid-{beta} toxicity. The Journal of Biological Chemistry. 280: 24941-7. PMID 15797869 DOI: 10.1074/Jbc.M413495200  0.784
2005 Castel H, Benchenane K, Fernandez-Monreal M, Lopez-Atalaya J, Bluthé R, Boulouard M, Dauphin F, MacKenzie ET, Dantzer R, Touzani O, Ali C, Vivien D. Physiological and pathological implications of the tPA/NR1 interaction: An immunization-based investigation Journal of Cerebral Blood Flow & Metabolism. 25: S579-S579. DOI: 10.1038/Sj.Jcbfm.9591524.0579  0.793
2005 Atalaya JL, Benchenane K, Castel H, Ali C, Petersen K, Vivien D. Desmoteplase (DSPA) does not interact with or cleave the NMDA receptor NR1 subunit: Possible molecular basis for improved tolerability in treatment of acute ischemic stroke Journal of Cerebral Blood Flow & Metabolism. 25: S578-S578. DOI: 10.1038/SJ.JCBFM.9591524.0578  0.753
2005 Benchenane K, Ali C, Brillault J, Berezowski V, Fernandez-Monreal M, Lopez-Attalaya JP, Chuquet J, Nouvelot A, MacKenzie ET, Dehouck M, Cecchelli R, Vivien D, Touzani O. Tissue-type plasminogen activator crosses the intact blood-brain barrier by LRP-mediated transcytosis: A phenomenon that is switched during oxygen glucose deprivation to an increased and LRP-independent process Journal of Cerebral Blood Flow & Metabolism. 25: S140-S140. DOI: 10.1038/sj.jcbfm.9591524.0140  0.808
2004 Liot G, Benchenane K, Léveillé F, López-Atalaya JP, Fernández-Monreal M, Ruocco A, Mackenzie ET, Buisson A, Ali C, Vivien D. 2,7-Bis-(4-amidinobenzylidene)-cycloheptan-1-one dihydrochloride, tPA stop, prevents tPA-enhanced excitotoxicity both in vitro and in vivo. Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism. 24: 1153-9. PMID 15529015 DOI: 10.1097/01.WCB.0000134476.93809.75  0.809
2004 Fernández-Monreal M, López-Atalaya JP, Benchenane K, Cacquevel M, Dulin F, Le Caer JP, Rossier J, Jarrige AC, Mackenzie ET, Colloc'h N, Ali C, Vivien D. Arginine 260 of the amino-terminal domain of NR1 subunit is critical for tissue-type plasminogen activator-mediated enhancement of N-methyl-D-aspartate receptor signaling. The Journal of Biological Chemistry. 279: 50850-6. PMID 15448144 DOI: 10.1074/jbc.M407069200  0.724
2004 Docagne F, Gabriel C, Lebeurrier N, Lesné S, Hommet Y, Plawinski L, Mackenzie ET, Vivien D. Sp1 and Smad transcription factors co-operate to mediate TGF-beta-dependent activation of amyloid-beta precursor protein gene transcription. The Biochemical Journal. 383: 393-9. PMID 15242331 DOI: 10.1042/Bj20040682  0.35
2004 Liot G, Gabriel C, Cacquevel M, Ali C, MacKenzie ET, Buisson A, Vivien D. Neurotrophin-3-induced PI-3 kinase/Akt signaling rescues cortical neurons from apoptosis. Experimental Neurology. 187: 38-46. PMID 15081586 DOI: 10.1016/j.expneurol.2004.01.002  0.692
2004 Fernández-Monreal M, López-Atalaya JP, Benchenane K, Léveillé F, Cacquevel M, Plawinski L, MacKenzie ET, Bu G, Buisson A, Vivien D. Is tissue-type plasminogen activator a neuromodulator? Molecular and Cellular Neurosciences. 25: 594-601. PMID 15080889 DOI: 10.1016/j.mcn.2003.11.002  0.787
2004 Benchenane K, López-Atalaya JP, Fernández-Monreal M, Touzani O, Vivien D. Equivocal roles of tissue-type plasminogen activator in stroke-induced injury. Trends in Neurosciences. 27: 155-60. PMID 15036881 DOI: 10.1016/j.tins.2003.12.011  0.797
2003 Buisson A, Lesne S, Docagne F, Ali C, Nicole O, MacKenzie ET, Vivien D. Transforming growth factor-beta and ischemic brain injury. Cellular and Molecular Neurobiology. 23: 539-50. PMID 14514014 DOI: 10.1023/A:1025072013107  0.813
2003 Docagne F, Ali C, Lesne S, Nicole O, MacKenzie ET, Buisson A, Vivien D. [Does transforming growth factor-beta (TGF-beta) act as a neuroprotective agent in cerebral ischemia?]. Journal De La Sociã©Tã© De Biologie. 197: 145-50. PMID 12910629  0.811
2003 Lesné S, Docagne F, Gabriel C, Liot G, Lahiri DK, Buée L, Plawinski L, Delacourte A, MacKenzie ET, Buisson A, Vivien D. Transforming growth factor-beta 1 potentiates amyloid-beta generation in astrocytes and in transgenic mice. The Journal of Biological Chemistry. 278: 18408-18. PMID 12626500 DOI: 10.1074/Jbc.M300819200  0.699
2003 Valable S, Bellail A, Lesné S, Liot G, Mackenzie ET, Vivien D, Bernaudin M, Petit E. Angiopoietin-1-induced PI3-kinase activation prevents neuronal apoptosis. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. 17: 443-5. PMID 12514118 DOI: 10.1096/Fj.02-0372Fje  0.369
2003 Gabriel C, Ali C, Lesné S, Fernández-Monreal M, Docagne F, Plawinski L, MacKenzie ET, Buisson A, Vivien D. Transforming growth factor alpha-induced expression of type 1 plasminogen activator inhibitor in astrocytes rescues neurons from excitotoxicity. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. 17: 277-9. PMID 12490542 DOI: 10.1096/Fj.02-0403Fje  0.725
2003 Docagne F, Ali C, Lesne S, Nicole O, MacKenzie ET, Buisson A, Vivien D. Le tranforming growth factor-β (TGF-p) a t-il un rôle neuroprotecteur dans l’ischémie cérébrale ? Journal De La SociéTé De Biologie. 197: 145-150. DOI: 10.1051/Jbio/2003197020145  0.755
2003 Vivien D, Fernández-Monreal M, Nicole O, Buisson A. Erratum: Reply to “Tissue plasminogen activator and NMDA receptor cleavage” Nature Medicine. 9: 975-975. DOI: 10.1038/NM0703-975B  0.663
2003 Vivien D, Monréal MF, Nicole O, Buisson A. Reply to "Tissue plasminogen activator and NMDA receptor cleavage" Nature Medicine. 9: 372-373. DOI: 10.1038/nm0403-372  0.638
2002 Docagne F, Nicole O, Gabriel C, Fernández-Monreal M, Lesné S, Ali C, Plawinski L, Carmeliet P, MacKenzie ET, Buisson A, Vivien D. Smad3-dependent induction of plasminogen activator inhibitor-1 in astrocytes mediates neuroprotective activity of transforming growth factor-beta 1 against NMDA-induced necrosis. Molecular and Cellular Neurosciences. 21: 634-44. PMID 12504596 DOI: 10.1006/Mcne.2002.1206  0.75
2002 Chuquet J, Benchenane K, Liot G, Fernández-Monreal M, Toutain J, Blanchet S, Eveno E, Auffray C, Piétu G, Buisson A, Touzani O, MacKenzie ET, Vivien D. Matching gene expression with hypometabolism after cerebral ischemia in the nonhuman primate. Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism. 22: 1165-9. PMID 12368653 DOI: 10.1097/00004647-200210000-00002  0.759
2002 Lesné S, Blanchet S, Docagne F, Liot G, Plawinski L, MacKenzie ET, Auffray C, Buisson A, Piétu G, Vivien D. Transforming growth factor-beta1-modulated cerebral gene expression. Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism. 22: 1114-23. PMID 12218417 DOI: 10.1097/00004647-200209000-00009  0.714
2001 Docagne F, Colloc'h N, Bougueret V, Page M, Paput J, Tripier M, Dutartre P, MacKenzie ET, Buisson A, Komesli S, Vivien D. A soluble transforming growth factor-beta (TGF-beta ) type I receptor mimics TGF-beta responses. The Journal of Biological Chemistry. 276: 46243-50. PMID 11544249 DOI: 10.1074/jbc.M010915200  0.695
2001 Ali C, Docagne F, Nicole O, Lesné S, Toutain J, Young A, Chazalviel L, Divoux D, Caly M, Cabal P, Derlon JM, MacKenzie ET, Buisson A, Vivien D. Increased expression of transforming growth factor-beta after cerebral ischemia in the baboon: an endogenous marker of neuronal stress? Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism. 21: 820-7. PMID 11435794 DOI: 10.1097/00004647-200107000-00007  0.725
2001 Nicole O, Ali C, Docagne F, Plawinski L, MacKenzie ET, Vivien D, Buisson A. Neuroprotection mediated by glial cell line-derived neurotrophic factor: involvement of a reduction of NMDA-induced calcium influx by the mitogen-activated protein kinase pathway. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 21: 3024-33. PMID 11312287 DOI: 10.1523/Jneurosci.21-09-03024.2001  0.727
2001 Nicole O, Docagne F, Ali C, Margaill I, Carmeliet P, MacKenzie ET, Vivien D, Buisson A. The proteolytic activity of tissue-plasminogen activator enhances NMDA receptor-mediated signaling. Nature Medicine. 7: 59-64. PMID 11135617 DOI: 10.1038/83358  0.723
2000 Ali C, Nicole O, Docagne F, Lesne S, MacKenzie ET, Nouvelot A, Buisson A, Vivien D. Ischemia-induced interleukin-6 as a potential endogenous neuroprotective cytokine against NMDA receptor-mediated excitotoxicity in the brain. Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism. 20: 956-66. PMID 10894179 DOI: 10.1097/00004647-200006000-00008  0.781
2000 Vivien D, Buisson A. Serine protease inhibitors: novel therapeutic targets for stroke? Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism. 20: 755-64. PMID 10826525 DOI: 10.1097/00004647-200005000-00001  0.663
2000 Bernaudin M, Bellail A, Marti HH, Yvon A, Vivien D, Duchatelle I, Mackenzie ET, Petit E. Neurons and astrocytes express EPO mRNA: oxygen-sensing mechanisms that involve the redox-state of the brain. Glia. 30: 271-8. PMID 10756076 DOI: 10.1002/(SICI)1098-1136(200005)30:3<271::AID-GLIA6>3.0.CO;2-H  0.369
1999 Ruocco A, Nicole O, Docagne F, Ali C, Chazalviel L, Komesli S, Yablonsky F, Roussel S, MacKenzie ET, Vivien D, Buisson A. A transforming growth factor-beta antagonist unmasks the neuroprotective role of this endogenous cytokine in excitotoxic and ischemic brain injury. Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism. 19: 1345-53. PMID 10598939 DOI: 10.1097/00004647-199912000-00008  0.711
1999 Docagne F, Nicole O, Marti HH, MacKenzie ET, Buisson A, Vivien D. Transforming growth factor-beta1 as a regulator of the serpins/t-PA axis in cerebral ischemia. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. 13: 1315-24. PMID 10428756 DOI: 10.1096/fasebj.13.11.1315  0.736
1998 Buisson A, Nicole O, Docagne F, Sartelet H, Mackenzie ET, Vivien D. Up-regulation of a serine protease inhibitor in astrocytes mediates the neuroprotective activity of transforming growth factor beta1. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. 12: 1683-91. PMID 9837858 DOI: 10.1096/Fasebj.12.15.1683  0.731
1998 Dennler S, Itoh S, Vivien D, ten Dijke P, Huet S, Gauthier JM. Direct binding of Smad3 and Smad4 to critical TGF beta-inducible elements in the promoter of human plasminogen activator inhibitor-type 1 gene. The Embo Journal. 17: 3091-100. PMID 9606191 DOI: 10.1093/emboj/17.11.3091  0.35
1998 Vivien D, Bernaudin M, Buisson A, Divoux D, MacKenzie ET, Nouvelot A. Evidence of type I and type II transforming growth factor-beta receptors in central nervous tissues: changes induced by focal cerebral ischemia. Journal of Neurochemistry. 70: 2296-304. PMID 9603194 DOI: 10.1046/J.1471-4159.1998.70062296.X  0.721
1995 Vivien D, Attisano L, Wrana JL, Massagué J. Signaling activity of homologous and heterologous transforming growth factor-beta receptor kinase complexes. The Journal of Biological Chemistry. 270: 7134-41. PMID 7706250 DOI: 10.1074/Jbc.270.13.7134  0.552
1995 Vivien D, Wrana JL. Ligand-induced recruitment and phosphorylation of reduced TGF-beta type I receptor. Experimental Cell Research. 221: 60-5. PMID 7589256 DOI: 10.1006/excr.1995.1352  0.557
1994 Vivien D, Bogdanowicz P, Boumediene K, Martiny L, Haye B, Pujol JP. Different phosphorylated forms of inositolphosphate glycan could be involved in the transforming growth factor-beta 1 (TGF-beta 1) signalling pathway. Cellular Signalling. 6: 173-80. PMID 8086280 DOI: 10.1016/0898-6568(94)90074-4  0.338
1993 Vivien D, Petitfrère E, Martiny L, Sartelet H, Galéra P, Haye B, Pujol JP. IPG (inositolphosphate glycan) as a cellular signal for TGF-beta 1 modulation of chondrocyte cell cycle. Journal of Cellular Physiology. 155: 437-44. PMID 8388000 DOI: 10.1002/Jcp.1041550302  0.351
Show low-probability matches.